Ohman K - Search Results

1

Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.

Carvalho T, Seeler JS, Ohman K, Jordan P, Pettersson U, Akusjärvi G, Carmo-Fonseca M, Dejean A. Carvalho T, et al. Among authors: ohman k. J Cell Biol. 1995 Oct;131(1):45-56. doi: 10.1083/jcb.131.1.45. J Cell Biol. 1995. PMID: 7559785 Free PMC article.

2

Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs.

Nordqvist K, Ohman K, Akusjärvi G. Nordqvist K, et al. Among authors: ohman k. Mol Cell Biol. 1994 Jan;14(1):437-45. doi: 10.1128/mcb.14.1.437-445.1994. Mol Cell Biol. 1994. PMID: 8264611 Free PMC article.

3

Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation.

Ohman K, Nordqvist K, Akusjärvi G. Ohman K, et al. Virology. 1993 May;194(1):50-8. doi: 10.1006/viro.1993.1234. Virology. 1993. PMID: 8386890

4

Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter.

Bondesson M, Ohman K, Manervik M, Fan S, Akusjärvi G. Bondesson M, et al. Among authors: ohman k. J Virol. 1996 Jun;70(6):3844-51. doi: 10.1128/JVI.70.6.3844-3851.1996. J Virol. 1996. PMID: 8648720 Free PMC article.

5

Effect of adenovirus-2 early region-4 products on e1-transformation.

Ohman K, Nordqvist K, Linder S, Akusjarvi G. Ohman K, et al. Int J Oncol. 1995 Mar;6(3):663-8. doi: 10.3892/ijo.6.3.663. Int J Oncol. 1995. PMID: 21556586

6

Characterization of factors involved in regulated adenovirus-2 major late pre-mRNA splicing.

Nordqvist K, Zerivitz K, Kreivi JP, Ohman K, Akusjärvi G. Nordqvist K, et al. Among authors: ohman k. Mol Biol Rep. 1990;14(2-3):203-4. doi: 10.1007/BF00360474. Mol Biol Rep. 1990. PMID: 2362574 No abstract available.

7

Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Malmqvist K, Ohman KP, Lind L, Nyström F, Kahan T. Malmqvist K, et al. Among authors: ohman kp. J Cardiovasc Pharmacol. 2003 Dec;42(6):719-26. doi: 10.1097/00005344-200312000-00005. J Cardiovasc Pharmacol. 2003. PMID: 14639093 Clinical Trial.

8

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

Malmqvist K, Kahan T, Edner M, Held C, Hägg A, Lind L, Müller-Brunotte R, Nyström F, Ohman KP, Osbakken MD, Ostergern J. Malmqvist K, et al. Among authors: ohman kp. J Hypertens. 2001 Jun;19(6):1167-76. doi: 10.1097/00004872-200106000-00023. J Hypertens. 2001. PMID: 11403367 Clinical Trial.

9

Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy.

Hallberg P, Lind L, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H. Hallberg P, et al. Among authors: ohman kp. BMC Cardiovasc Disord. 2003 Sep 18;3:11. doi: 10.1186/1471-2261-3-11. Epub 2003 Sep 18. BMC Cardiovasc Disord. 2003. PMID: 13678427 Free PMC article. Clinical Trial.

10

Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.

Nyström F, Malmqvist K, Ohman KP, Kahan T. Nyström F, et al. Among authors: ohman kp. J Hypertens. 2002 Aug;20(8):1527-33. doi: 10.1097/00004872-200208000-00015. J Hypertens. 2002. PMID: 12172314 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page